Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Analysis of uterine evacuation methods in postabortion care after implementation of a surveillance network (CLAP MUSA-Network) at a university hospital

  • Nelio N. Veiga-Junior,

    Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Department of Obstetrics and Gynecology, University of Campinas (UNICAMP) School of Medicine, Campinas, SP, Brazil

  • Caroline Eugeni,

    Roles Data curation, Formal analysis, Investigation, Writing – original draft

    Affiliation Department of Obstetrics and Gynecology, University of Campinas (UNICAMP) School of Medicine, Campinas, SP, Brazil

  • Beatriz D. Kajiura,

    Roles Data curation, Formal analysis, Investigation, Writing – original draft

    Affiliation Department of Obstetrics and Gynecology, University of Campinas (UNICAMP) School of Medicine, Campinas, SP, Brazil

  • Priscilla B. F. Dantas,

    Roles Data curation, Formal analysis, Investigation, Writing – original draft

    Affiliation Department of Obstetrics and Gynecology, University of Campinas (UNICAMP) School of Medicine, Campinas, SP, Brazil

  • Caroline B. Trabach,

    Roles Data curation, Formal analysis, Investigation, Writing – original draft

    Affiliation Department of Obstetrics and Gynecology, University of Campinas (UNICAMP) School of Medicine, Campinas, SP, Brazil

  • Aline A. Junqueira,

    Roles Data curation, Formal analysis, Investigation, Writing – original draft

    Affiliation Department of Obstetrics and Gynecology, University of Campinas (UNICAMP) School of Medicine, Campinas, SP, Brazil

  • Carina C. Nunes,

    Roles Data curation, Formal analysis, Investigation, Writing – original draft

    Affiliation Department of Obstetrics and Gynecology, University of Campinas (UNICAMP) School of Medicine, Campinas, SP, Brazil

  • Luiz F. Baccaro

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing

    luiz.baccaro@gmail.com

    Affiliation Department of Obstetrics and Gynecology, University of Campinas (UNICAMP) School of Medicine, Campinas, SP, Brazil

Abstract

Background

Management of uterine evacuation is essential for increasing safe abortion care. Monitoring through surveillance systems tracks changes in clinical practice and provides information to improve equity in abortion care quality.

Objective

This study aimed to evaluate the frequency of manual vacuum aspiration (MVA) and medical abortion (MA), and identify the factors associated with each uterine evacuation method after surveillance network installation at a Brazilian hospital.

Methods

This cross-sectional study included women admitted for abortion or miscarriage to the University of Campinas Women’s Hospital, Brazil, between July 2017 and November 2020. The dependent variables were the use of MVA and MA with misoprostol. The independent variables were the patients’ clinical and sociodemographic data. The Cochran–Armitage, chi-square, and Mann–Whitney U tests, as well as multiple logistic regression analysis, were used to compare uterine evacuation methods.

Results

We enrolled 474 women in the study, 91.35% of whom underwent uterine evacuation via uterine curettage (78.75%), MVA (9.46%), or MA (11.54%). MVA use increased during the study period (Z = 9.85, p < 0.001). Admission in 2020 (odds ratio [OR] 64.22; 95% confidence interval [CI] 3.79–1086.69) and lower gestational age (OR 0.837; 95% CI 0.724–0.967) were independently associated with MVA, whereas the only factor independently associated with MA was a higher education level (OR 2.66; 95% CI 1.30–5.46).

Conclusion

MVA use increased following the installation of a surveillance network for good clinical practice. Being part of a network that encourages the use of evidence-based methods provides an opportunity for healthcare facilities to increase access to safe abortions.

Introduction

Estimates suggest that 208 million women worldwide become pregnant every year and approximately 25% of all pregnancies end in abortion [1]. One in two abortions, mostly in developing countries, is unsafe, leading to approximately 47000 yearly maternal deaths due to complications [13]. In Brazil, despite the National Abortion Survey showing a drop in abortion hospitalization rates [4], 200 women die annually from unsafe abortions. Furthermore, 20% of women up to the age of 40 have had an illegal abortion, half of whom were subsequently hospitalized for abortion-related complications [57]. Restrictive laws only permitting pregnancy termination in cases of sexual violence, risk of maternal death, or fetal anencephaly limit the provision of safe abortion, allowing avoidable morbidity and mortality to persist [7,8].

Improving women’s access to postabortion care methods is recommended by the World Health Organization (WHO) guidelines for reducing unsafe abortion [1,9,10]. The management of uterine evacuation is essential in comprehensive abortion care and reduces abortion-related complications. Further, it minimizes the costs associated with treating unsafe abortion complications [1,9,11,12]. Therefore, efforts to replace uterine dilatation and curettage (D&C), which is associated with a higher risk of uterine perforation and intrauterine synechiae, with alternative methods are recommended [10,13]. Medical abortion (MA) using pharmacological drugs such as mifepristone or misoprostol is safe and effective, is associated with fewer complications, avoids surgery-related risks, and is feasible in low-resource settings [9,14]. Additionally, the recommended surgical uterine evacuation technique is manual vacuum aspiration (MVA), which is safer, faster, less painful, and associated with fewer complications than D&C [15].

The method of uterine evacuation highlights the quality of a healthcare facility’s abortion care [1618]. Respectful services and women-centered counseling provide positive experiences and reduce adverse abortion-related outcomes. In the decision-making process, women choose MA four times more frequently than other methods. For those who prefer surgical methods, MVA leads to fewer side effects and greater satisfaction than sharp curettage [15]. Monitoring these indicators for safe abortions enables assessment of disparities in the quality of care provided to these women.

Ensuring a standard in abortion healthcare services may identify which evidence-based practices should be prioritized for data collection [10]. Surveillance systems can improve the quality of care and help countries monitor and evaluate programs aimed at preventing unplanned pregnancies as well as maternal morbidity and mortality. Moreover, abortion surveillance programs can track changes in clinical practice patterns and provide the data necessary to inform health policies [10,16,18]. In a previous study, we demonstrated how the use of a surveillance system increased contraceptive use before discharge in women hospitalized for abortion complications [19].

In Brazil, even with a decrease in abortions, almost 70% of all pregnancies are unplanned [4,20]. Restrictive laws increase the burden of unsafe abortions, which remain an important health issue [21]. The method of uterine evacuation impacts abortion safety provision, and monitoring clinical practices over time is necessary to improve postabortion care and foster improved public policies [1,10,19]. Therefore, this study aimed to evaluate the frequency of MVA and MA use in a hospital in Brazil and identify factors associated with the method of uterine evacuation after the implementation of a surveillance network.

Methods

MUSA network

The multicentric MUSA (mujeres en situación de aborto) Network was created by the Latin American Center for Perinatology (CLAP) to improve care for women undergoing abortions in Latin America and the Caribbean [22]. The network includes several hospitals, classified as sentinel centers, that periodically send pregnancy data for registration in the Perinatal Computerized System (SIP), software developed by CLAP that aids in recording data related to pregnancy and epidemiological monitoring. Our institution, the University of Campinas Women’s Hospital (UNICAMP), is a tertiary referral hospital located in an urban setting in southeast Brazil. The hospital handles cases of pregnancy-related complications in municipalities within the region and sees an average of 250 births and 20 cases of first-trimester pregnancy loss per month. Our institution has been a sentinel center of the CLAP MUSA-Network since July 2017. The National Research Ethics Committee approved data collection at the hospital prior to the commencement of the study (approval number: 62778316.6.1001.5404).

The sentinel centers of the CLAP MUSA-Network regularly provide data on maternal morbidity in early pregnancy loss, uterine evacuation methods for termination, incidence of termination-related complications, incidence of preoperative antibiotic use, and contraceptive prescription before hospital discharge. SIP enables epidemiological monitoring and comparisons between centers over time. Additionally, representatives from each center hold regular online meetings to discuss the collected data, conduct scientific talks on the health of women undergoing abortions, and encourage good clinical practice for safe abortions. The CLAP MUSA-Network protocol and specific methodological details have been published elsewhere [23].

Study design and data collection

This cross-sectional prospective study was conducted between July 2017 and November 2020. We included all women admitted to our institution for an abortion for any legal reason and those considered to be in postabortion circumstances (including miscarriage and early pregnancy loss). The exclusion criteria were bleeding during pregnancy with no confirmed abortion and ectopic or molar pregnancies. Data recorded in SIP are based on information collected through face-to-face interviews with women during hospitalization and a review of the data in their medical records. All participants provided written informed consent. Minors and their legal guardians provided informed assent and consent, respectively. The Research Ethics Committee of our institution (CEP UNICAMP) approved the study protocol (approval number: 93060618.9.1001.5404).

In all abortion cases, MA was performed using vaginal administration of misoprostol, since mifepristone use has not yet been approved in Brazil. Further, surgical approaches comprised MVA and D&C. All medical staff members were trained to perform each uterine evacuation method. At the time of hospitalization, the women received information about all the methods, although the approach used was determined by a healthcare provider.

The dependent variables for analysis were each uterine evacuation method, namely MVA and MA with misoprostol only (when there was no need for further uterine evacuation). The independent variables were age, education, marital status, medical history, number of pregnancies, number of births, number of abortions, body mass index (BMI), active smoking, illegal drug use, alcohol use, planned pregnancy, pregnancy resulting from contraceptive failure, date of admission for abortion, legal abortion, gestational age, presence of complications, and other admission data.

Power calculation

This study used a convenience sample of all women who fulfilled the selection criteria and provided informed consent between 07/01/2017 and 11/16/2020. We calculated the statistical power of the study using the estimate in a descriptive study with a categorical variable, setting the alpha level of significance or type I error at 5% and the sample error at 5%. The power of the sample to estimate the prevalence of MVA and MA were 99.4% and 97.3%, respectively.

Statistical analyses

First, a descriptive analysis of the data was performed. The continuous variables are presented as the mean and standard deviation or the median and interquartile range. Relative frequencies were calculated for the categorical variables. The Cochran–Armitage trend test was performed with quarterly analyses to assess whether the rates of MVA and MA use changed over time. Thereafter, chi-square (categorical variables) and Mann–Whitney U tests (continuous variables) were conducted to compare the clinical and sociodemographic factors associated with performing MVA and MA. Finally, to evaluate the factors independently associated with MVA and MA, two multiple logistic regression models were constructed using stepwise criteria for variable selection. The significance level was set at 5% for all tests, and all analyses were performed using the SAS System for Windows version 9.2 (SAS Institute Inc., Cary, NC, USA).

Results

During the study period, 474 women with a mean age of 30.01 (± 7.48) years and median age of 30 (12–48) years were enrolled. The mean gestational age was 11.03 (± 3.56) weeks, and 30.38% of the women had not previously been pregnant. Most women did not use contraception (75.5%), and 69.85% of the pregnancies were unplanned. Of the 474 cases, 67 (14.1%) were legal abortions, and 66 of the 67 (98.5%) pregnancies resulted from sexual violence. Details of the patients’ clinical and sociodemographic characteristics are presented in Table 1.

thumbnail
Table 1. Clinical and sociodemographic characteristics (n = 474).

https://doi.org/10.1371/journal.pone.0296009.t001

During the evaluation period, 433 (91.35%) women underwent uterine evacuation. The most common method was D&C, which was performed in 341 patients (78.75%). MVA was performed in 41 (9.46%) women, and MA using misoprostol was administered to 50 women (11.54%). At least one complication was observed in 24 of the 474 (5.06%) women, all of whom underwent D&C. Over the course of the surveillance period, we observed a significant increase in the use of MVA (Cochran–Armitage test: Z = 9.85; p < 0.001); however, no difference in the use of MA was observed (Z = 1.35; p = 0.178) (Fig 1).

thumbnail
Fig 1. Methods of uterine evacuation between July 2017 and November 2020 by trimestral period.

Captions: MVA- manual vacuum aspiration; MA- medical abortion Cochran-Armitage test: MVA: Z = 9.85, P <0.001; MA: Z = 1.35; P = 0.178.

https://doi.org/10.1371/journal.pone.0296009.g001

Considering the factors associated with MVA, the procedure was performed more frequently in women with a lower education level (p = 0.04), those admitted in 2020 (p < 0.01), and those with no previous pregnancies (p < 0.01), lower BMI (p < 0.01), lower gestational age (p = 0.03), shorter symptom duration (p = 0.02), and higher hemoglobin levels (p = 0.04). In the multiple logistic regression analysis, admission in 2020 (odds ratio [OR] 64.22; 95% confidence interval [CI] 3.79–1086.69) and lower gestational age (OR 0.837; 95% CI 0.724–0.967) were independently associated with MVA. Regarding MA, women with a higher education level underwent this procedure more frequently (p = 0.03). Furthermore, the regression analysis revealed that a higher education level was the only factor independently associated with MA (OR 2.66; 95% CI 1.30–5.46) (Table 2).

thumbnail
Table 2. Factors associated with uterine evacuation method (n = 381)a.

https://doi.org/10.1371/journal.pone.0296009.t002

Discussion

The present study describes the uterine evacuation methods performed at a university hospital with an established surveillance network that encourages safe abortion practices (the CLAP MUSA-Network). During the observation period, MVA use increased, while the rate of MA remained unchanged. Women admitted in 2020 and those with a lower gestational age had an increased likelihood of undergoing MVA. In contrast, a higher level of education was associated with MA use.

In surgical abortion, replacing D&C with MVA is the key to preventing unsafe abortions [1,16]. Nevertheless, D&C is the second most frequently performed obstetric procedure in Brazilian public health facilities after vaginal delivery [20]. According to a national mixed methods study, only 45% of women who used legal abortion services underwent MVA [24]. Furthermore, several initiatives to replace D&C have not achieved positive results, differing from our findings. No overall improvement in MVA frequency was observed in Honduras and Malawi’s postabortion care, mostly because of the reluctance of healthcare providers to abandon D&C [25,26]. The present analysis shows a significant trend toward increased MVA use following implementation of the MUSA Network. Although the rate of MVA use was relatively low (9.46%) for most of the evaluation period, we observed a considerable increase in the final 6 months of the study, with the rate exceeding 60% in the last 3 months of 2020. The CLAP MUSA-Network promoted regular scientific meetings with other sentinel centers, reinforcing the importance of safe abortions and improving medical staff training. Nevertheless, we observed a relatively long period before the routine use of MVA was established in the hospital. We believe that this is because the hospital administrative team should also have been made aware of the use of safer uterine evacuation techniques. The meetings promoted by the CLAP MUSA Network were essential for raising awareness among the health unit’s management team to ensure the acquisition of hospital supplies necessary to routinely perform MVA on a permanent basis. This finding supports the idea that monitoring clinical care promotes and improves comprehensive abortion care [23,27]. Similar to our study, institutions in Bangladesh have also used monitoring to evaluate the progress achieved in replacing D&C with MVA and MA [28]. Additionally, the routine Abortion Surveillance program in the United States reports on the use of different methods to analyze the safety of abortion practices and has fostered a reduction in unplanned pregnancies [27].

MA is considered an effective alternative to surgical procedures, with a success rate of 75–90% [28,29]. In the present study, MA was performed in 11.54% of the patients, and no increase in its use was observed during the study period. In the United States, approximately 40% of all abortions in 2018 were performed exclusively using medication [27]. In Brazil, mifepristone is not available, and misoprostol is only used for uterine emptying in hospitalized patients [8]. Compared to surgical procedures, MA takes longer to complete and requires a longer hospital stay; thus, it may not be the first choice for women or medical professionals [1,12].

Follow-up after MA is based on the self-recognition of signs and symptoms [6]. Healthcare professionals might believe it is safer to recommend MA to women who may more readily recognize warning signs, preemptively seek medical services, and have a better understanding of the choices available [30]. In our study, approximately 20% of the women had a higher education level and a 2.3-times greater chance of receiving MA. Although we did not evaluate the decision-making process regarding the abortion method, other studies have reported similar results. Even when the procedures were performed by the same organization and professional, women who chose MA had a higher level of education [31,32].

This study has some limitations. First, the cross-sectional nature of the study means that a cause-and-effect relationship could not be established. Second, differentiating between provoked and spontaneous abortions was not possible, except in cases of legal induction. Regarding MA, the use of misoprostol in Brazil is restricted to the hospital setting, which prevents dispensation for home use. It was not possible to consider the influence of the misoprostol dosage used during the study period. Finally, the patients were only analyzed during hospitalization and were not followed up after discharge. Although the uterine evacuation methods are discussed with patients, the final decision lies with the responsible doctor. Nevertheless, we believe that our results are valid. The implementation of the CLAP MUSA-Network for the surveillance and implementation of good clinical practices has ensured the monitoring of clinical decisions inside institutions and promoted healthcare providers’ ongoing education, leading to a reduction in the use of D&C. The provision of safe abortion methods is central to the WHO and FIGO goal for equitable access to abortion care and improved women’s reproductive health [10,16].

Being part of a network that encourages the use of evidence-based clinical practices provides an opportunity for healthcare facilities to set priorities, evaluate outcomes, and implement policy changes to improve safe abortion access. Continuous monitoring of therapeutic indicators and medical education can help reduce abortion-related morbidities and mortality, and address the healthcare needs and rights of women.

References

  1. 1. World Health Organization. Abortion care guideline Geneva: World Health Organization; 2022.
  2. 2. Safe Abortion: Technical and Policy Guidance for Health Systems. 2nd ed. Geneva: World Health Organization; 2012.
  3. 3. Ganatra B, Gerdts C, Rossier C, et al. Global, regional, andsubregional classification of abortions by safety, 2010–14: estimatesfrom a Bayesian hierarchical model. Lancet 2017; 390:2372–81. pmid:28964589
  4. 4. Diniz D, Medeiros M, Madeiro A. National Abortion Survey—Brazil, 2021. Cien Saude Colet. 2023 Jun;28(6):1601–1606.
  5. 5. Cardoso BB, Vieira FMSB, Saraceni V. Abortion in Brazil: what do the official data say?. Cad. Saúde Pública 2020; 36 (1): e00188718.
  6. 6. Diniz D, Medeiros M, Madeiro A. National Abortion Survey 2016. Ciênc Saúde Coletiva 2017; 22:653–60.
  7. 7. Malta M, Wells S, LeGrand S, Seixas M, Baptista A, da Silva CMFP, et al. Abortion in Brazil: the case for women’s rights, lives, and choices. Lancet Public Health 2019; 4: e552. pmid:31677774
  8. 8. Domingues RMSM Fonseca SC, Leal MC Aquino EML, Menezes GMS. Unsafe abortion in Brazil: A systematic review of the scientific production, 2008–2018. Cad Saude Pública 2020; 36:e00190418.
  9. 9. World Health Organization. Medical management of abortion. Geneva: World Health Organization; 2018.
  10. 10. World Health Organization. Standards for improving quality of maternal and newborn care in health facilities. Geneva: World Health Organization, 2016.
  11. 11. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health. 2014;2:e323–33. pmid:25103301
  12. 12. Kapp N, Lohr PA. Modern methods to induce abortion: Safety, efficacy and choice. Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:37–44. pmid:32029379
  13. 13. Ireland LD, Gatter M, Chen AY. Medical Compared With Surgical Abortion for Effective Pregnancy Termination in the First Trimester. Obstetrics & Gynecology 2015; 126: 8–22. pmid:26241252
  14. 14. Ngoc NTN, Winikoff B, Clark S, Ellertson C, Am KG, Hieu DT, et al. Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam. International Family Planning Perspectives 1999, 25:10–14.
  15. 15. Moreau C., Trussell J., Desfreres J., & Bajos N. (2011). Medical vs. surgical abortion: the importance of women’s choice. Contraception, 84(3), 224–229. pmid:21843684
  16. 16. Faundes A, Comendant R, Dilbaz B, Jaldesa G, Leke R, Mukherjee B, et al. Preventing unsafe abortion: Achievements and challenges of a global FIGO initiative. Best Practice & Research Clinical Obstetrics & Gynaecology 2020; 62:101–12. pmid:31331743
  17. 17. Footman K. Revolution in abortion care? Perspectives of key informants on the importance of abortion method choice in the era of telemedicine. Sex Reprod Health Matters. 2023 Dec;31(1):2149379. pmid:36876426
  18. 18. Jatlaoui TC, Eckhaus L, Mandel MG, Nguyen A, Oduyebo T, Petersen E, et al. Abortion Surveillance—United States, 2016. MMWR Surveill Summ 2019; 29; 68:1–41.
  19. 19. Veiga-Junior NN, Cavalari CA, Eugeni C, Kajiura BD, Stefano N, Baccaro LF. Post-abortion contraception before hospital discharge after installation of a surveillance network in Brazil. Int J Gynecol Obstet 2020; 150: 200–205.
  20. 20. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Atenção humanizada ao abortamento: norma técnica. 2. ed. Ministério da Saúde; 2011.
  21. 21. Romero M, Gomez Ponce de Leon R, Baccaro LF, et al. Abortion- related morbidity in six Latin American and Caribbean countries: findings of the WHO/HRP multi-country survey on abortion (MCS-A). BMJ Global Health 2021;6:e005618. pmid:34417270
  22. 22. Serruya SJ, Gómez Ponce de León R, Bahamondes MV, De Mucio B, Costa ML, Duran P, et al. EviSIP: using evidence to change practice through mentorship—an innovative experience for reproductive health in the Latin American and Caribbean regions. Glob Health Action 2020; 13:1811482. pmid:32867629
  23. 23. Gomez Ponce de Leon R, Baccaro LF, Rubio Schweizer G, et al. Building a network of sentinel centres for the care of women in an abortion situation: advances in Latin America and the Caribbean. BMJ Global Health 2022; 7:e010059 pmid:36283731
  24. 24. Madeiro AP, Diniz D. Legal abortion services in Brazil—a national study. Cien Saude Colet 2016; 21:563–72. pmid:26910163
  25. 25. Chinchilla AL, Flores IF, Morales AF, de Gil MP. Changes in the use of manual vacuum aspiration for postabortion care within the public healthcare service network in Honduras. Int J Gynaecol Obstet 2014; 126:S24–7. pmid:24800657
  26. 26. Cook S, de Kok B, Odland ML. “It’s a very complicated issue here”: understanding the limited and declining use of manual vacuum aspiration for postabortion care in Malawi: a qualitative study. Health Policy Plan 2017; 32(3):305–13. pmid:27616307
  27. 27. Kortsmit K, Jatlaoui TC, Mandel MG, Reeves JA, Oduyebo T, Petersen E, et al. Abortion Surveillance—United States, 2018. MMWR Surveill Summ 2020; 69:1–29.
  28. 28. Begum F, Zaidi S, Fatima P, Shamsuddin L, Anowar-ul-Azim AK, Begum RA. Improving manual vacuum aspiration service delivery, introducing misoprostol for cases of incomplete abortion, and strengthening postabortion contraception in Bangladesh. Int J Gynaecol Obstet. 2014 Jul;126 Suppl 1:S31–5. pmid:24792403
  29. 29. von Hertzen H, Piaggio G, Huong NT, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet 2007; 369:1938. pmid:17560446
  30. 30. Faúndes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynaecol Obstet 2007; 99:172. pmid:17961570
  31. 31. Cameron ST, Glasier AF, Logan J, et al. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh. BJOG Int J Obstet Gynaecol. 1996;103(12):1222–1229. pmid:8968240
  32. 32. Rørbye C, Nørgaard M, Nilas L. Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study. Hum Reprod. 2005;20(3):834–838. pmid:15618257